The current valuation score of Valneva SE is 7.18, ranking 202 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.57, which is -5081.93% below the recent high of 177.67 and -3204.28% above the recent low of -117.84.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.